These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 6210519

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In vitro and in vivo antibacterial activity of moxalactam, an oxa-beta-lactam antibiotic.
    Goto S.
    Rev Infect Dis; 1982; 4 Suppl():S501-10. PubMed ID: 6218559
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity, efficacy, and pharmacology of moxalactam, a new beta-lactam antibiotic.
    Snepar R, Poporad G, Romano J, Levison ME.
    Antimicrob Agents Chemother; 1981 Nov; 20(5):642-7. PubMed ID: 6459763
    [Abstract] [Full Text] [Related]

  • 5. Third-generation cephalosporins: a critical evaluation.
    Barriere SL, Flaherty JF.
    Clin Pharm; 1984 Nov; 3(4):351-73. PubMed ID: 6432420
    [Abstract] [Full Text] [Related]

  • 6. Successful moxalactam therapy for gram-negative bacillary meningitis in neonates.
    Ramos OM, Kaplan SL, Mason EO, Denson S, Pickering LK.
    South Med J; 1982 May; 75(5):632-3. PubMed ID: 6210970
    [Abstract] [Full Text] [Related]

  • 7. Moxalactam disodium (Moxam).
    Med Lett Drugs Ther; 1982 Feb 05; 24(602):13-4. PubMed ID: 6460163
    [No Abstract] [Full Text] [Related]

  • 8. Moxalactam in serious infections: clinical, bacteriologic, and pharmacokinetic studies.
    Giamarellou H, Tsagarakis J, Daikos GK.
    Rev Infect Dis; 1982 Feb 05; 4 Suppl():S629-38. PubMed ID: 6218576
    [Abstract] [Full Text] [Related]

  • 9. Clinical evaluation of moxalactam: evidence of decreased efficacy in gram-positive aerobic infections.
    Salzer W, Pegram PS, McCall CE.
    Antimicrob Agents Chemother; 1983 Apr 05; 23(4):565-70. PubMed ID: 6222696
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Therapy of lower respiratory tract infections with moxalactam.
    Lentino JR, Rytel MW, Moore E.
    Antimicrob Agents Chemother; 1981 May 05; 19(5):801-6. PubMed ID: 6457557
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics and bacteriological efficacy of moxalactam (LY127935), netilmicin, and ampicillin in experimental gram-negative enteric bacillary meningitis.
    Schaad UB, McCracken GH, Loock CA, Thomas ML.
    Antimicrob Agents Chemother; 1980 Mar 05; 17(3):406-11. PubMed ID: 6448576
    [Abstract] [Full Text] [Related]

  • 17. Emergence of resistance to beta-lactam and aminoglycoside antibiotics during moxalactam therapy of Pseudomonas aeruginosa infections.
    Preheim LC, Penn RG, Sanders CC, Goering RV, Giger DK.
    Antimicrob Agents Chemother; 1982 Dec 05; 22(6):1037-41. PubMed ID: 6218778
    [Abstract] [Full Text] [Related]

  • 18. [Clinical study on 6059-S in children (author's transl)].
    Yanagisawa K, Ide K, Hoshina H, Ichihashi H.
    Jpn J Antibiot; 1981 May 05; 34(5):757-63. PubMed ID: 6457174
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy of moxalactam in an animal model of subcutaneous abscesses: penetration into infected sites and in vivo activity against Bacteroides fragilis.
    Bartlett JG, Joiner KA, Dezfulian M, Marien GJ.
    Rev Infect Dis; 1982 May 05; 4 Suppl():S664-9. PubMed ID: 6218580
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of moxalactam.
    Reed MD, Bertino JS, Aronoff SC, Speck WT, Blumer JL.
    Clin Pharm; 1982 May 05; 1(2):124-34. PubMed ID: 6224626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.